Suppr超能文献

2019 年冠状病毒病在感染奥密克戎变异株的儿童中的严重程度。

Coronavirus Disease 2019 Disease Severity in Children Infected With the Omicron Variant.

机构信息

Hamad Medical Corporation, Doha, Qatar.

Department of Medicine, Weill Cornell Medicine, New York, New York and Doha, Qatar.

出版信息

Clin Infect Dis. 2022 Aug 24;75(1):e361-e367. doi: 10.1093/cid/ciac275.

Abstract

SHORT SUMMARY

Severe acute respiratory syndrome coronavirus 2 infection from the Omicron variant in children/adolescents is less severe than infection from the Delta variant. Those 6 to <18 years also have less severe disease than those <6 years old.

BACKGROUND

There are limited data assessing coronavirus 2019 (COVID-19) disease severity in children/adolescents infected with the Omicron variant.

METHODS

We identified children and adolescents <18 years of age with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection with Delta and propensity score-matched controls with Omicron variant infection from the National COVID-19 Database in Qatar. Primary outcome was disease severity, determined by hospital admission, admission to the intensive care unit (ICU), or mechanical ventilation within 14 days of diagnosis, or death within 28 days.

RESULTS

Among 1735 cases with Delta variant infection between 1 June and 6 November 2021, and 32 635 cases with Omicron variant infection between 1 January and 15 January 2022, who did not have prior infection and were not vaccinated, we identified 985 propensity score-matched pairs. Among those who were Delta infected, 84.2% had mild, 15.7% had moderate, and 0.1% had severe/critical disease. Among those who were Omicron infected, 97.8% had mild, 2.2% had moderate, and none had severe/critical disease (P < .001). Omicron variant infection (vs Delta) was associated with significantly lower odds of moderate or severe/critical disease (adjusted odds ratio [AOR], 0.12; 95% confidence interval [CI], .07-.18). Those aged 6-11 and 12 to <18 years had lower odds of developing moderate or severe/critical disease compared with those younger than age 6 years (aOR, 0.47; 95% CI, .33-.66 for 6-11 year olds; aOR, 0.45; 95% CI, .21-.94 for 12 to <18 year olds).

CONCLUSIONS

Omicron variant infection in children/adolescents is associated with less severe disease than Delta variant infection as measured by hospitalization rates and need for ICU care or mechanical ventilation. Those 6 to <18 years of age also have less severe disease than those <6 years old.

摘要

摘要

与感染德尔塔变异株相比,儿童和青少年感染奥密克戎变异株的严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2)感染程度较轻。6 岁以下儿童的疾病严重程度也低于 6 岁以上儿童。

背景

目前评估儿童和青少年感染奥密克戎变异株的 2019 年冠状病毒病(COVID-19)严重程度的数据有限。

方法

我们从卡塔尔国家 COVID-19 数据库中确定了 2021 年 6 月 1 日至 11 月 6 日期间感染德尔塔变异株的年龄小于 18 岁的儿童和青少年,以及 2022 年 1 月 1 日至 1 月 15 日期间感染奥密克戎变异株的年龄小于 18 岁且无既往感染和未接种疫苗的病例,共 1735 例,并对这些病例进行了配对。在这些病例中,985 例为匹配病例。在感染德尔塔变异株的病例中,84.2%为轻症,15.7%为中症,0.1%为重症/危重症;在感染奥密克戎变异株的病例中,97.8%为轻症,2.2%为中症,无一例为重症/危重症(P<0.001)。与感染德尔塔变异株相比,感染奥密克戎变异株的儿童和青少年中出现中症或重症/危重症的几率显著降低(校正比值比 [AOR],0.12;95%置信区间 [CI],0.07-0.18)。与 6 岁以下儿童相比,6-11 岁和 12-17 岁的儿童发生中症或重症/危重症的几率较低(AOR,0.47;95%CI,0.33-0.66 岁;AOR,0.45;95%CI,0.21-0.94 岁)。

结论

与德尔塔变异株感染相比,儿童和青少年感染奥密克戎变异株的疾病严重程度较轻,表现在住院率以及需要重症监护病房(ICU)护理或机械通气方面。与 6 岁以下儿童相比,6-17 岁儿童的疾病严重程度也较轻。

相似文献

1
Coronavirus Disease 2019 Disease Severity in Children Infected With the Omicron Variant.
Clin Infect Dis. 2022 Aug 24;75(1):e361-e367. doi: 10.1093/cid/ciac275.
3
Severity of Illness in Persons Infected With the SARS-CoV-2 Delta Variant vs Beta Variant in Qatar.
JAMA Intern Med. 2022 Feb 1;182(2):197-205. doi: 10.1001/jamainternmed.2021.7949.
5
Clinical severity of Omicron and Delta SARS-CoV-2 infections in children.
Pediatr Int. 2024 Jan-Dec;66(1):e15777. doi: 10.1111/ped.15777.
9
Favorable outcomes of COVID-19 in vaccinated hematopoietic stem cell transplant recipients: A single-center experience.
Transpl Infect Dis. 2023 Jun;25(3):e14024. doi: 10.1111/tid.14024. Epub 2023 Feb 7.
10
Comparing COVID-19 severity in patients hospitalized for community-associated Delta, BA.1 and BA.4/5 variant infection.
Front Public Health. 2024 Feb 21;12:1294261. doi: 10.3389/fpubh.2024.1294261. eCollection 2024.

引用本文的文献

1
Early symptoms and 12-week follow-up of pediatric omicron infections during the Beijing outbreak.
Front Pediatr. 2025 Aug 5;13:1389572. doi: 10.3389/fped.2025.1389572. eCollection 2025.
2
Duration of COVID-19 symptoms in children: a longitudinal study in a Rio de Janeiro favela, Brazil.
BMJ Open. 2025 Jul 6;15(7):e095622. doi: 10.1136/bmjopen-2024-095622.
3
Impact of COVID-19 on Surgical Procedural Utilization.
Cureus. 2025 Apr 22;17(4):e82772. doi: 10.7759/cureus.82772. eCollection 2025 Apr.
7
Coronavirus disease 2019 infection severity among different variants in children under 2-years old in Brazil.
Clinics (Sao Paulo). 2025 Feb 20;80:100592. doi: 10.1016/j.clinsp.2025.100592. eCollection 2025.
8
Risk factors for relapse and aggravation in membranous nephropathy after COVID-19 infection.
BMC Nephrol. 2025 Feb 11;26(1):71. doi: 10.1186/s12882-025-04000-x.
9
The Incidence and Clinical Characteristics of COVID-19 in Children With IBD During the Omicron Wave: A Single-Center Experience in China.
Gastroenterol Res Pract. 2025 Jan 16;2025:1868214. doi: 10.1155/grp/1868214. eCollection 2025.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验